AT-001 Uses, Dosage, Side Effects and more
AT-001 is under investigation in clinical trial NCT03062384 (AT-001 for Long-term Preservation of Brain Health in Aging).
| Trade Name | AT-001 |
| Generic | AT-001 |
| Type | |
| Formula | C17H10F3N5O3S |
| Weight | Average: 421.35 Monoisotopic: 421.045644865 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
